InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 265026

Sunday, 06/19/2016 2:11:51 PM

Sunday, June 19, 2016 2:11:51 PM

Post# of 346487
David Carbone : Peregrine Pharmaceuticals KOL and IASLC President:

No better background for a Sunrise, than with blue, beautiful skies

June 25, 2016

The event will support groundbreaking lung cancer research conducted at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and the Blue Beautiful Skies Fund (under the direction of David P. Carbone, MD, PhD, lung cancer researcher, clinician and cancer survivor).

http://bluebeautifulskies.org/events/


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News